Literature DB >> 7790544

CT-guided pleural needle biopsy in the diagnosis of malignant mesothelioma.

M Metintaş1, N Ozdemir, S Işiksoy, T Kaya, M Ekici, S Erginel, E Harmanci, P Erdinç, N Ulgey, F Alataş.   

Abstract

OBJECTIVE: Our goal was to determine the sensitivity of CT-guided closed pleural needle biopsy (CPNB) for the histopathologic diagnosis of diffuse malignant pleural mesothelioma (DMPM).
MATERIALS AND METHODS: Thirty patients with DMPM were studied with CT-guided CPNB. Tumor specimens were classified according to their cell types.
RESULTS: In 25 (83.3%) patients, the diagnosis was made by CT-guided CPNB. The remaining five patients were diagnosed by thoracoscopy, thoracotomy, or excisional biopsy of the chest wall mass. Pneumothorax was observed in 9.5% of patients and local seeding of tumor in 21.7% of patients who underwent CPNB.
CONCLUSION: Properly performed CPNB under CT guidance may yield an increased sensitivity for the diagnosis of diffuse malignant pleural mesothelioma.

Entities:  

Mesh:

Year:  1995        PMID: 7790544     DOI: 10.1097/00004728-199505000-00006

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  11 in total

1.  BTS statement on malignant mesothelioma in the UK, 2007.

Authors: 
Journal:  Thorax       Date:  2007-11       Impact factor: 9.139

Review 2.  Diagnosis and management of malignant pleural effusions: state of the art in 2017.

Authors:  Neeraj R Desai; Hans J Lee
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 3.  Pleural controversies: image guided biopsy vs. thoracoscopy for undiagnosed pleural effusions?

Authors:  Giles Dixon; Duneesha de Fonseka; Nick Maskell
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

4.  Potential of dual time point FDG-PET imaging in differentiating malignant from benign pleural disease.

Authors:  Ayse Mavi; Sandip Basu; Tevfik F Cermik; Muammer Urhan; Mehdi Bathaii; Dhurairaj Thiruvenkatasamy; Mohamed Houseni; Simin Dadparvar; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2009-05-27       Impact factor: 3.488

Review 5.  Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.

Authors:  Kazuhiro Kitajima; Hiroshi Doi; Kozo Kuribayashi
Journal:  Jpn J Radiol       Date:  2016-05-24       Impact factor: 2.374

Review 6.  Radiotherapy for malignant pleural mesothelioma.

Authors:  E Chapman; E G Berenstein; M Diéguez; Z Ortiz
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

7.  Surgical staging and resection of malignant pleural mesothelioma.

Authors:  Lawrence B Brown; Frank Corl; Shanda H Blackmon
Journal:  J Thorac Dis       Date:  2020-12       Impact factor: 3.005

Review 8.  Malignant mesothelioma.

Authors:  Alastair J Moore; Robert J Parker; John Wiggins
Journal:  Orphanet J Rare Dis       Date:  2008-12-19       Impact factor: 4.123

9.  A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma.

Authors:  S Bydder; M Phillips; D J Joseph; F Cameron; N A Spry; Y DeMelker; A W Musk
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

Review 10.  Clinical staging of malignant pleural mesothelioma: current perspectives.

Authors:  Maria Bonomi; Costantino De Filippis; Egesta Lopci; Letizia Gianoncelli; Giovanna Rizzardi; Eleonora Cerchiaro; Luigi Bortolotti; Alessandro Zanello; Giovanni Luca Ceresoli
Journal:  Lung Cancer (Auckl)       Date:  2017-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.